نتائج البحث

Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency

• Authors : Arriva Pharmaceuticals, Inc.

• Source: A Phase 1B/2A Study to Evaluate the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects

تفاصيل العنوان

Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency

• Authors : Arriva Pharmaceuticals, Inc.

• Source: Phase I Safety Investigation of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha

تفاصيل العنوان

Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin Deficiency

• Authors : National Heart, Lung, and Blood Institute (NHLBI); Alpha-1 Foundation; University of Florida

• Source: Preclinical & Phase I/II Trials of AAV-AAT Vectors: Phase I Trial of Intramuscular Injection of a Recombinant Adeno-Associated Virus Alpha

تفاصيل العنوان

Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency

• Authors : University of Pittsburgh

تفاصيل العنوان

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

• Source: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Fazirsiran in the Treatment of Alpha-1 Antitrypsin

تفاصيل العنوان

NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD)

• Source: Phase 1/2 Multicenter, Open-label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-3001 in Participants with Alpha-1 Antitrypsin

تفاصيل العنوان

Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD) (SPARTA)

• Source: A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1 Proteinase Inhibitor (Human) in

تفاصيل العنوان

Phase III, Efficacy and Safety of 'Kamada-AAT for Inhalation' (InnovAATe)

• Authors : Syneos Health

• Source: Prospective Phase 3 Multi-center 2-Year Placebo Controlled Double Blind Study to Evaluate the Efficacy and Safety of Kamada-AAT for Inhalation 80 Mg/Day in Alpha-1

تفاصيل العنوان

Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema (ELEVAATE)

• Source: Phase 2, Double-Blind, Randomized, Active-Control, Parallel Group Study to Assess the Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety of SAR447537 (INBRX-101) Compared to Plasma-Derived

تفاصيل العنوان

A Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110 (REWRITE)

• Source: A Phase 1/2a, Single- and Multiple-dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KRRO 110 in Healthy Adult Volunteers and in Adult Participants

تفاصيل العنوان